Letters to the Editor
Inherited susceptibility to rheumatic disease From Professor V Wright and Dr C J Eastmond Rheumatism Research Unit, University of Leeds Dear Sir, We read with considerable interest the text of Dr D A Brewerton's excellent and thoughtprovoking Samuel Hyde Lecture recently published in the Journal (May, p 331). Samuel Hyde, who was a spa physician at the end of the last century, might have found the subject hard-going, but would have listened and read with interest.
Whilst recognizing the importance of the association between HLA-B27 and the seronegative spondarthritides as an explanation of the genetic interrelationships between the individual syndromes included under this umbrella title (Wright & Moll 1976) , Dr Brewerton has indicated that there are fundamental questions which require solution if we are to understand fully how a gene lying in the major histocompatibility complex of the sixth human autosome determines the development of these rheumatic diseases. The finding of the association between each of these and HLA-B27 is only a first step which has probably raised more questions than it has answered. The importance of raising these questions at this time is to clarify the current state of our knowledge and thereby to plan future studies. Some of these will be within the scope of experienced clinicians. Others, however, will require the resources of the epidemiologist; others will benefit from the skills of the geneticist and, in others, the immunogeneticist, biochemist and bacteriologist will probably have their own important contributions to make.
One question that constantly recurs is whether the predisposing gene for these disorders is HLA-B27 itself or a linked gene. If it is a linked gene, then do all HLA-B27-positive individuals have that gene? We need to know whether patients with and without HLA-B27 have the same disease, judged clinically, radiologically, immunologically and biochemically. Brewerton has suggested, along with others (Eastmond & Woodrow 1977a), that genes for psoriasis and inflammatory bowel disease probably have an important part to play, particularly in those patients who develop ankylosing spondylitis in the absence ofHLA-B27. There is some uncertainty as to the frequency of ankylosing spondylitis in the population and thereby in HLA-B27-positive individuals. We need to be able to compare an accurate estimate of this frequency with the HLA-B27-positive relatives of patients with ankylosing spondylitis. Analyses using currently available figures (Woodrow 1977 , Wright & Eastmond 1977 suggest that, in addition to the gene in the major histocompatibility complex, there is a second independent segregating gene necessary for the development of ankylosing spondylitis. At present nothing more is known about this gene.
Whilst genetic factors are obviously of importance in this group of diseases, there is good circumstantial evidence that environmental factors are also necessary. In some forms of Reiter's syndrome specific microorganisms have been implicated, whereas in the most usual form in the UK the organism causing nonspecific urethritis remains unknown. Whilst concordance for ankylosing spondylitis in identical twins is possibly common, discordance has been noted by several observers (Moesmann 1960 , Eastmond & Woodrow 1977b , thereby implicating environmental factors in the pathogenesis of the disease. Recently, the possible role of a specific microorganism has been studied, although the results to date are not entirely conclusive.
Many patients do not fit into any clearly-defined diagnostic category, but with continued observation the diagnosis may become more certain. Within this group of conditions, certain patterns which seem to be associated with the tissue antigen HLA-B27 can be recognized. These include a lower limb oligoarthritis of the type seen in Reiter's syndrome but without any associated features, dactylitis of the fingers and toes, and inflammatory symptoms of the peripheral entheses. It is possibly here that tissue typing may have a diagnostic role.
Continued work in this important area of rheumatology is dependent upon the availability of the necessary technology. Tissue-typing antisera are scarce and naturally their use for organ matching for transplantation will continue to be a major demand. It is important to recognize, however, the considerable value the availability of these antisera has been to our improved, though still grossly inadequate, understanding of this group of rheumatic diseases. Without the initial discovery by Dr Brewerton and his colleagues, and the considerable number of investigations which that discovery stimulated throughout the world, our knowledge of these disorders would have remained even more incomplete. We would hope that there will continue to be close cooperation between the imrnunogeneticists, the National Tissue Typing Laboratory and Regional Blood Transfusion Services and clinicians, so that the stimulus we have all been given by these recent discoveries may ultimately benefit the rheumatic patient. The young chronic sick From Dr Frank Tail Senior Medical Officer, Department ofHealth and Social Security Dear Sir, I attended the symposium on the young chronic sick reported in the June issue of the Journal (pp 437---453), and reading the papers again reminded me how heartened I had been to find that the problems considered were the same problems that had been identified as being of major importance by those of us within the DHSS concerned with the development of services for this group. Heartened because central planning will be effective only if it facilitates the development of clinical practice.
It is interesting to consider the relationship between planning and practice in the context of the special allocations of central funds for the development of hospital units for the younger disabled (1971) . When it was realized that many young patients were occupying beds in hospital wards that were predominantly populated by the elderly, the administrative response was to provide these beds in a setting which was more appropriate to the age, interests and environmental needs of the younger patients. Dr P J R Nichols (p 442) says that doubts have been cast on the wisdom of this policy, but perhaps it would be more accurate to say that there has been a dramatic change in the clinical practice which the policy was intended to benefit.
The papers read at the symposium, and the ensuing discussion, clearly showed that in consider-ing the needs of the younger disabled, including those with deteriorating and progressive conditions, no role for any part of the total service can be satisfactorily identified and defined outside the context of the contributions to that service from health authorities, local authority social services departments, housing authorities and the voluntary associations -contributions which will have both domiciliary and residential components. Visits to younger disabled units throughout the country have shown that there is a wide variation in operational policies, and estimates of need for provision from different Areas show a range as wide as those reported at the Durham symposium and quoted by Dr D S Wilson (p 448).
It seems probable that these differences are less an expression of differences in prevalence and more an indication of the ways in which it has been possible to develop a more flexible response to both individual and family need, by the growth in domiciliary services (both statutory and voluntary), housing adaptations, increasingly sophisticated aids and environmental control systems, and, perhaps most important of all, discussion with the disabled population themselves. These are exciting developments, but it is important not to lose sight of the fact that the provision of a flexible response also requires that we can accept the need for continuing care and treatment, be it only palliative, and the wish to remain dependent on others. As the contributions to the symposium show, we are concerned with the continuum of disability, and we must ensure that it is matched by a continuum of services. My colleague, Dr K A Exley, and I did not react very favourably to many of the statements in the publication by Professor Matthews in the Lancet (1964, ii, 577) . We thought it portrayed a much too negative approach in many respects, but we agreed about the need for collaboration between physiologist and clinician. While its very provocativeness might have served a useful purpose when it was written, Dr Critchley is right to point out that any momentum it may have generated then has not been sustained. Indeed, we would have doubts
